CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.85+0.19 (+11.45%)
Close on Nov 17, 2026Market cap $32.54MP/E –Yield –
Cel Sci profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2014 it was -10359.6%, against -5746.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Sep 30, 2014 | -10359.6% | −4612.7 |
| FY2013 | Sep 30, 2013 | -5746.8% | +332.0 |
| FY2012 | Sep 30, 2012 | -6078.8% | −3389.7 |
| FY2011 | Sep 30, 2011 | -2689.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -25671.8% | – |
See a number that looks wrong?